Ha HI - Search Results

1

Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis.

Kim JH, Kim SI, Park EY, Ha HI, Kim JW, Coleman RL, Bristow RE, Park SY, Fotopoulou C, Lim MC. Kim JH, et al. Among authors: ha hi. Gynecol Oncol. 2023 Oct 27;179:24-32. doi: 10.1016/j.ygyno.2023.10.018. Online ahead of print. Gynecol Oncol. 2023. PMID: 39491079

2

The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis.

Eoh KJ, Park EY, Chang YJ, Ha HI, Hong J, Huang D, Nam EJ, Lim MC. Eoh KJ, et al. Among authors: ha hi. Gynecol Oncol. 2021 Oct;163(1):142-147. doi: 10.1016/j.ygyno.2021.07.028. Epub 2021 Jul 23. Gynecol Oncol. 2021. PMID: 34304906

3

Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.

Ha HI, Cho SH, Lim J, Lee YJ, Yoo CW, Won YJ, Lim MC. Ha HI, et al. Gynecol Oncol. 2021 Dec;163(3):506-510. doi: 10.1016/j.ygyno.2021.09.014. Epub 2021 Oct 1. Gynecol Oncol. 2021. PMID: 34602286

4

Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancer.

Ha HI, Park EY, Eoh KJ, Lee YJ, Seo SS, Kang S, Park SY, Lim MC. Ha HI, et al. Gynecol Oncol. 2022 Feb;164(2):415-420. doi: 10.1016/j.ygyno.2021.12.013. Epub 2021 Dec 17. Gynecol Oncol. 2022. PMID: 34924242

5

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis.

Baek MH, Park EY, Ha HI, Park SY, Lim MC, Fotopoulou C, Bristow RE. Baek MH, et al. Among authors: ha hi. J Clin Oncol. 2022 May 20;40(15):1659-1670. doi: 10.1200/JCO.21.02085. Epub 2022 Feb 21. J Clin Oncol. 2022. PMID: 35188810

6

Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01).

Kim JH, Lee DE, Lee Y, Ha HI, Chang YJ, Chang SJ, Park SY, Lim MC. Kim JH, et al. Among authors: ha hi. J Gynecol Oncol. 2022 Jul;33(4):e54. doi: 10.3802/jgo.2022.33.e54. Epub 2022 May 31. J Gynecol Oncol. 2022. PMID: 35712968 Free PMC article. Clinical Trial.

7

Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.

Ha HI, Kim JH, Lim J, Song YJ, Won YJ, Lim MC. Ha HI, et al. J Gynecol Oncol. 2024 Jan;35(1):e31. doi: 10.3802/jgo.2024.35.e31. Epub 2023 Dec 5. J Gynecol Oncol. 2024. PMID: 38072401 Free PMC article.

8

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.

Ha HI, Ryu JS, Shim H, Kong SY, Lim MC. Ha HI, et al. J Gynecol Oncol. 2020 Nov;31(6):e83. doi: 10.3802/jgo.2020.31.e83. J Gynecol Oncol. 2020. PMID: 33078592 Free PMC article.

9

How do we perform hyperthermic intraperitoneal chemotherapy in ovarian cancer? -a narrative review.

Ha HI, Lim MC. Ha HI, et al. Gland Surg. 2021 Mar;10(3):1235-1243. doi: 10.21037/gs-20-425. Gland Surg. 2021. PMID: 33842270 Free PMC article. Review.

10

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry.

Ha HI, Chang HK, Park SJ, Lim J, Won YJ, Lim MC. Ha HI, et al. Obstet Gynecol Sci. 2021 Sep;64(5):444-453. doi: 10.5468/ogs.21116. Epub 2021 Aug 17. Obstet Gynecol Sci. 2021. PMID: 34399564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters